Newsletter

Blue Chip Stocks

The Trillion Dollar Club: 16 Stocks Are In It and Here Are The 8 That Are Not The Magnificent Seven or SpaceX

The Trillion Dollar Club (i.e. stocks valued at over US$1tn) now boasts 16 members. When Apple became the first to crack the US$1tn mark in 2018, it was a major milestone for global investment markets. 8 years on, there are 16 companies in the trillion dollar club and while the majority are in the US and…

ByNick Sundich3 days ago

Clinuvel Pharmaceuticals (ASX:CUV): Nearly 7 years on from the FDA’s approval of Scenesse, this company is now at a crossroads

Clinuvel Pharmaceuticals (ASX:CUV) is a perculiar company. It is a rare example of an Australian biotech that not only survived the long march from discovery to approval but did so with discipline, profitability and independence. Its 2019 FDA approval for Scenesse was the defining moment in its history, the point at which a decades‑long scientific…

ByNick Sundich4 days ago

5 Non Resources Companies On the ASX You Never Knew Used To Be Digging For Pay Dirt

You could argue there are only resources and non resources companies on the ASX because the former category makes up a third of listings and no individual non-resources stock category comes close to making up that number. The resources sector is a grind and the odds are stacked against you. Often, microcap explorers give up…

ByNick Sundich5 days ago

Netflix (NDQ:NFLX): It Reaches Over 1bn People But Still Claims Its Just Getting Started

Netflix (NDQ:NFLX) has become one of the most recognisable companies in global media, a business that reshaped how people consume entertainment and forced an entire industry (the media and entertainment) to re‑engineer itself. Yet the question now confronting investors is deceptively simple: can its growth continue? The company delivered US$45.2bn revenue last year, up from…

ByNick SundichJuly 6, 2026

ASX Stocks Vulnerable To a Sell Off From One Bad Regulatory Decision: Here are 6 of them!

There are plenty of ASX Stocks vulnerable to a sell off for many reasons including bad trading updates, downgraded guidance, bad results or the departure of long-term leadership. Those are the most common reasons, but this article looks at one of the rarer reasons (but still as harmful: a bad regulatory decision. When a business…

ByNick SundichJuly 6, 2026

Pexa (ASX:PXA) risks losing $70m in revenue after an IPART Ruling – the music has truly stopped!

PEXA (ASX:PXA) investors absorbed a sharp shock this morning, with the stock falling roughly 18% in the first ninety minutes of trade after a regulatory decision that strikes directly at the company’s long‑running ambition to expand its digital conveyancing footprint. The sell‑off could be put down to a reaction to the headline, but we think it…

ByNick SundichJuly 3, 2026

Suncorp (ASX:SUN) holds upper-end margins through a A$250m hazard overrun

Suncorp Group (ASX:SUN) reaffirms upper-end FY26 ITR margins despite a A$250m nat hazard overrun as the FY27 reinsurance program is placed.

ByCharlie YouldenJuly 3, 2026

ANZ was the Best Big 4 Bank in FY26 by a wide margin! But will the momentum continue?

The battle for 'Best Big 4 Bank in FY26' wasn't even a contest. ANZ closed the financial year up 16% while CBA (ASX: CBA) and NAB (ASX: NAB) shares have both fallen and Westpac (ASX: WBC) has only managed a 3% gain. For a bank that spent much of the past two years being treated as…

ByNick SundichJuly 2, 2026

ASX Stocks to Buy in FY27: Here Are Our Top 10 To Watch!

Today is the first day of the new financial year, and we think plenty of investors are wondering which ASX Stocks to Buy in FY27. Stocks Down Under recaps 10 stocks that it thinks is set for a good 12 months ahead. 10 ASX Stocks to Buy in FY27 Goodman Group (ASX:GMG) Goodman enters FY27 with…

ByNick SundichJuly 1, 2026

Proxy Advisory Firms: Should Australian Investors Take These Quiet Powerbrokers Seriously?

Proxy advisory firms occupy an unusual position in Australian markets being amongst arguably the most influential powerbrokers but are neither regulators nor shareholders. They are peculiar to say the least How are they influential? Their recommendations can swing AGM outcomes, shape board behaviour, and influence the fate of multi‑billion‑dollar transactions. They sit in the background of…

ByNick SundichJune 29, 2026

the Kick-ass Multipurpose WordPress Theme

Blue Chip Stocks

The Trillion Dollar Club: 16 Stocks Are In It and Here Are The 8 That Are Not The Magnificent Seven or SpaceX

Clinuvel Pharmaceuticals (ASX:CUV): Nearly 7 years on from the FDA’s approval of Scenesse, this company is now at a crossroads

5 Non Resources Companies On the ASX You Never Knew Used To Be Digging For Pay Dirt

Netflix (NDQ:NFLX): It Reaches Over 1bn People But Still Claims Its Just Getting Started

ASX Stocks Vulnerable To a Sell Off From One Bad Regulatory Decision: Here are 6 of them!

Pexa (ASX:PXA) risks losing $70m in revenue after an IPART Ruling – the music has truly stopped!

Suncorp (ASX:SUN) holds upper-end margins through a A$250m hazard overrun

ANZ was the Best Big 4 Bank in FY26 by a wide margin! But will the momentum continue?

ASX Stocks to Buy in FY27: Here Are Our Top 10 To Watch!

Proxy Advisory Firms: Should Australian Investors Take These Quiet Powerbrokers Seriously?

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Blue Chip Stocks

Stocks in Spotlight

Add Your Heading Text Here